Evidence map›Paper›PMID 40666409›Full record

ArticleRwanda journal of medicine and health sciences2021

The Comparability of Lipid-based and Body Mass Index-based Cardiovascular Disease Risk Scores: Using the Rwanda 2012-2013 Non-communicable Diseases Risk Factors Survey Data.

Jean Berchmans Niyibizi, Kufre Joseph Okop, Naomi Levitt, Stephen Rulisa, Seleman Ntawuyirushintege, David Tumusiime, Alypio Nyandwi, Evariste Ntaganda, Birhanu Ayele, Charlotte Bavuma

Abstract read
In one paragraph

Article in Rwanda journal of medicine and health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Systematic review and meta-analysis of cardiovascular disease risk among hypertensive patients in Africa.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jean Berchmans NiyibiziSingle Project Implementation Unit, University of Rwanda, Kicukiro, Kigali, Rwanda.
Kufre Joseph OkopChronic Diseases Initiative for Africa (CDIA), University of Cape Town, Rondebosch, Western Cape, South Africa.
Naomi LevittChronic Diseases Initiative for Africa (CDIA), University of Cape Town, Rondebosch, Western Cape, South Africa.
Stephen RulisaSchool of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Seleman NtawuyirushintegeSingle Project Implementation Unit, University of Rwanda, Kicukiro, Kigali, Rwanda.
David TumusiimeSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Alypio NyandwiRepublic of Rwanda Ministry of Health, Kigali, Rwanda.
Evariste NtagandaRwanda Biomedical Center, Kigali, Rwanda.
Birhanu AyeleDivision of Epidemiology and Biostatistics, Stellenbosch University, Stellenbosch, Western Cape, South Africa.
Charlotte BavumaSchool of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Rwanda, cardiovascular diseases (CVDs) ranked second of the most common cause of death in 2016. CVD risk score tools have been recommended to identify people at high risk for management. Objective: To assess the comparability of body mass index (BMI)-based and lipid-based CVD risk scores in Rwandan population. Methods: Secondary analysis was conducted on 4185 study participants extracted from the dataset of Rwanda 2012-2013 non-communicable diseases risk factors survey. Individual CVD risk scores were calculated using both BMI-based and lipid-based algorithms, one at a time. Spearman rank's coefficient and Cohen's Kappa coefficient were used to compare the two tools. Results: About 63.5% of participants were women. There was a significant positive correlation between BMI-based algorithm and lipid-based algorithm vis-à-vis a 10-year CVD risk prediction (Spearman rank correlation coefficients > 0.90, p<0.001) considering either men, women or overall study participants. There was a moderate agreement between BMI-based and lipid-based algorithms vis-à-vis CVD risk characterization, kappa = 0.52; p-value p<0.001 considering either overall study participants or men and kappa = 0.48; p-value p<0.001 considering women. Conclusion: The findings from this study suggest the use of BMI-based algorithm, a cost effective tool compared to lipid-based tool, can be alternatively used in resource-limited settings.

Indexed as

algorithmsCardiovascular diseasesRwanda

Identifiers

PMID40666409
PMCPMC12257239

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.